DAS(002421)

Search documents
达实智能(002421) - 2024年度独立董事述职报告 - 陈以增
2025-04-21 13:05
深圳达实智能股份有限公司 独立董事述职报告 各位股东: 本人陈以增,自 2019 年 9 月起,一直担任深圳达实智能股份有限公司(以 下简称"公司")独立董事。在 2024 年度,本人持续认真学习《公司法》《上 市公司治理准则》《上市公司独立董事管理办法》及《公司章程》《独立董事工 作制度》等规定,秉着严谨认真、勤勉尽责、诚实独立的原则履行独立董事的相 关职责,通过积极参加董事会和股东大会谨慎审核公司提交的各项议案、参与董 事会专门委员会、开展现场工作等方式忠实履行了独立董事的职责和义务,切实 维护了公司整体利益和全体股东的合法权益。 现将本人 2024 年履职情况报告如下: 基本情况 (一)个人工作履历、专业背景及兼职情况 本人陈以增,男,1971 年 9 月出生,北京航空航天大学硕士,东北大学博 士,香港理工大学博士后,长期从事工业工程与金融系统工程方面的教学、科研 工作,入选中国高被引学者。曾任上海大学管理学院教授、博士生导师、系主任、 副院长,上海市 MBA 教育指导委员会委员,中国质量协会学术教育工作委员会 委员,上海质量协会常务理事,上海运筹协会理事。现任公司第八届董事会独立 董事、审计委员会委员 ...
达实智能(002421) - 2024 Q4 - 年度财报
2025-04-21 12:45
Strategic Development - In 2024, the company successfully operated the DSTE strategic management process and established a three-year healthy development strategy for 2025-2027, focusing on solidifying foundations, building capabilities, and restructuring[5]. - The company plans to accelerate strategic transformation in 2025, focusing on product, enterprise, and hospital markets while enhancing operational efficiency[7]. - The company aims to improve its integrated R&D capabilities and digital support capabilities as part of its strategic transformation[7]. - The company plans to implement a mid-term business development plan from 2025 to 2027, focusing on "healthy growth" and enhancing core capabilities[57]. Financial Performance - The company's operating revenue for 2024 was ¥3,170,839,643.97, a decrease of 17.28% compared to ¥3,833,109,486.66 in 2023[24]. - The net profit attributable to shareholders for 2024 was ¥25,881,175.35, down 77.45% from ¥114,777,861.74 in 2023[24]. - The net profit after deducting non-recurring gains and losses for 2024 was ¥1,595,484.70, a decline of 97.85% compared to ¥74,222,842.12 in 2023[24]. - The overall gross margin increased by 3.58 percentage points to 27.47% compared to 23.89% in 2023[55]. - The revenue from the smart space overall solution business was CNY 2.660 billion, a decline of 18.89% from CNY 3.280 billion last year, while the smart space product and technical service business grew by 12.9% to CNY 330 million[56]. Project Development and Innovation - The company signed key projects with renowned enterprises, including China Merchants Bank Global Headquarters and BYD Smart Factory, enhancing its competitiveness in the smart park market[6]. - The company provided intelligent services for seven metro lines in Shenzhen, Chengdu, and Foshan, significantly improving urban transportation convenience[6]. - The company’s innovative solutions expanded into intercity railways, securing three intelligent system orders in 2024[6]. - The company has developed a series of IoT application systems, including energy-saving control systems and smart management systems for hospitals and transportation, enhancing operational efficiency[41]. - The company is developing an AIoT smart management platform aimed at enhancing operational efficiency in key industries such as healthcare and transportation[81]. Sustainability and ESG Initiatives - The company’s ESG case study won the Annual Best ESG Practice Award from the China Listed Companies Association, highlighting its commitment to sustainable development[5]. - The company has achieved carbon neutrality for four consecutive years at its headquarters, reducing energy consumption by 5.32% compared to 2023[68]. - The company has been recognized for its continuous investment in energy-saving and low-carbon initiatives, winning the annual best ESG practice case award from the China Listed Companies Association[60]. - The company has implemented a series of environmental management regulations and emergency plans to comply with environmental laws and regulations, achieving ISO 14001 certification[177]. Market Position and Competitive Edge - The company is positioned as a leading provider of intelligent IoT solutions, leveraging its self-developed AIoT platform and smart terminal products[33]. - The company anticipates a shift in the competitive landscape from price competition to value competition in the intelligent business sector[35]. - The company aims to enhance its service value by extending its offerings throughout the entire lifecycle of projects, from construction to operation[35]. - The company has a strong customer base, including notable clients such as Alibaba and ByteDance, showcasing its competitive edge in the smart space sector[52]. Research and Development - R&D investment amounted to ¥164,642,858.78 in 2024, a decrease of 4.55% from ¥172,484,980.59 in 2023[84]. - The proportion of R&D investment to operating revenue increased to 5.19% in 2024 from 4.50% in 2023, reflecting a 0.69% increase[84]. - The company is focusing on building a self-controlled medical information ecosystem to replace foreign technology products in medical systems[83]. - The company is committed to enhancing its digital operating capabilities through advanced AI algorithms for energy consumption optimization[85]. Corporate Governance - The company has established a series of internal control systems to ensure compliance with laws and regulations, including internal audit and major information reporting systems[124]. - The company has a governance structure that includes a board of directors, supervisory board, and management team, ensuring a clear distribution of powers[121]. - The company emphasizes the importance of a diverse board composition to enhance decision-making quality and innovation capabilities[122]. - The company has committed to a profit distribution policy that ensures at least 30% of the average distributable profit over the past three years is distributed as cash dividends[125]. Shareholder Engagement - In 2024, the company organized 7 large investor communication events, attracting over 100 institutional and individual investors, with more than 110,000 views during the semi-annual report presentation[127]. - The company achieved a 100% response rate to investor inquiries, addressing 34 questions through an interactive platform[128]. - The company has conducted 11 cash dividend distributions since its listing in 2010, amounting to a cumulative total of 529 million RMB[125]. Employee and Compensation - The company reported a total employee count of 2,279, with 1,017 in the parent company and 1,262 in major subsidiaries[162]. - Total employee compensation for the reporting period was approximately ¥527.99 million, with ¥444.56 million included in total operating costs, accounting for 14.53% of total costs[165]. - The number of core technical personnel increased by 30.46% to 454, representing 19.92% of total employees, with their labor costs making up 17.59% of total employee compensation[165]. Legal and Compliance - The company has been engaged in ongoing litigation with a total involved amount of approximately 1.06 billion RMB, with various stages of enforcement and execution currently in progress[195]. - The company has not reported any major changes in the feasibility of investment projects[104]. - The company has not undergone any bankruptcy restructuring during the reporting period[194]. - The company has maintained effective internal controls over financial reporting as of December 31, 2024, according to the internal control audit report[175].
达实智能:2024年净利润2588.12万元,同比下降77.45%
快讯· 2025-04-21 12:44
达实智能(002421)公告,2024年营业收入31.71亿元,同比下降17.28%。归属于上市公司股东的净利 润2588.12万元,同比下降77.45%。公司拟向全体股东每10股派发现金红利0.05元(含税),送红股0股(含 税),不以公积金转增股本。 ...
达实智能(002421) - 关于智慧医院项目签约的公告
2025-04-10 09:45
证券代码:002421 证券简称:达实智能 公告编号:2025-016 深圳达实智能股份有限公司 关于智慧医院项目签约的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导 性陈述或重大遗漏。 特别提示: 1.合同的履行存在受不可抗力的影响所造成的风险,敬请广大投资者注意 投资风险。 2.项目顺利实施后,将有利于公司在粤港澳大湾区打造智慧医院标杆,助 力智慧医疗行业发展,也将对公司未来业绩产生有利影响。 4. 资金来源:100%政府资金。 5. 服务内容:达实久信将依托多年来在医疗洁净领域积累的丰富经验,为 其提供自设计至交付的全流程服务。服务内容涵盖净化、防辐射及医用气体工程。 其中净化工程涉及八至十三层检验科、输血科、手术室、ICU 等工作区域与配 套用房;防辐射工程包含负一层影像科及机房相应控制室、七层内镜中心及十一 层手术室的防护;医用气体工程含氧气站、医用中心供氧管道系统、医用中心吸 引设备、医用中心吸引管道系统、医用空气压缩设备、医用空气管道系统。手术 室包含 3 间日间手术室、3 间百级(3 间铅防护手术室,其中 1 间为复合 CT 手 术室)、5 间千级(其中 3 ...
达实智能(002421) - 关于智慧医院项目签约的公告
2025-04-10 09:45
证券代码:002421 证券简称:达实智能 公告编号:2025-015 深圳达实智能股份有限公司 关于智慧医院项目签约的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导 性陈述或重大遗漏。 特别提示: 1.合同的履行存在受不可抗力的影响所造成的风险,敬请广大投资者注意 投资风险。 2.项目顺利实施后,将有利于公司在粤港澳大湾区打造智慧医院标杆,助 力智慧医疗行业发展,也将对公司未来业绩产生有利影响。 一、 合同签署情况 深圳达实智能股份有限公司(以下简称"公司")近日协同深圳市尚润科工 集团有限公司作为联合体,与深圳市宝安区建筑工务署、深圳招商房地产有限公 司就宝安区中医院扩建工程(二期)智能化项目在深圳市宝安区建筑工务署签署 了合同,合同金额 2642.3 万元。 二、 项目基本情况 1. 项目名称:宝安区中医院扩建工程(二期)智能化项目。 2. 项目背景:宝安区中医院规划总床位 1000 张,根据《深圳市医疗机构 设置数据采集表》,2025 年末可供应床位 963 张,东院区二期项目建设完成后 增加床位 305 张,合计 1268 张床位。项目新建面积 99543 平方米 ...
达实智能:达实久信签署5738.49万元智慧医院项目
快讯· 2025-04-10 09:44
达实智能(002421)公告,近日,公司全资子公司江苏达实久信医疗科技有限公司就宝安区中医院扩建 工程(二期)医疗专项项目签署了正式合同,合同金额5738.49万元。项目位于深圳市宝安区裕安二路深圳 市宝安区中医院,合同工期总日历天数为228天。项目金额占公司2023年度经审计营业收入的1.5%,预 计会对公司未来年度的净利润产生积极的影响。 ...
达实智能(002421) - 关于深圳机场至大亚湾城际客票系统项目中标的公告
2025-04-08 09:45
关于深圳机场至大亚湾城际客票系统项目中标的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导 性陈述或重大遗漏。 深圳达实智能股份有限公司(以下简称"达实智能"或"公司")近日收到 《中标通知书》,中标深圳机场至大亚湾城际深圳机场至坪山段工程客票系统设 备及服务项目,中标金额为 5647.01 万元,项目基本情况如下: 一、 项目基本情况 证券代码:002421 证券简称:达实智能 公告编号:2025-014 深圳达实智能股份有限公司 1. 项目背景:深大城际深圳机场至坪山段位于深圳市北部,线路起自深圳 市宝安机场 T4 枢纽,途经深圳市宝安、龙华、龙岗和坪山四区,终至深圳市聚 龙站,线路全长 68.9 公里。设车站 11 座,其中,枢纽站和换乘站 10 座,普 通站 1 座,均为地下线和地下站。 2. 招标人:深圳市地铁集团有限公司(以下简称"深铁集团")。 3. 中标金额:56,470,068.00 元。 4. 服务内容:公司将基于自主研发的 AI 视觉通行控制系统、车站票务系统、 一体化客服中心等软硬件产品,聚合多种创新性应用,为该项目提供围绕自动售 检票的"AI+智慧交 ...
达实智能(002421) - 关于使用部分闲置募集资金进行现金管理的进展公告
2025-03-24 11:46
证券代码:002421 证券简称:达实智能 公告编号:2025-013 深圳达实智能股份有限公司 关于使用部分闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导 性陈述或重大遗漏。 深圳达实智能股份有限公司(以下简称"达实智能"或"公司")于 2024 年 8 月 22 日召开了第八届董事会第十三次会议,审议通过了《关于使用部分闲 置募集资金进行现金管理的议案》,为提高资金使用效率,增加存储收益,保护 投资者的权益,在确保不影响募集资金投资项目建设、不变相改变募集资金使用 用途、不影响公司正常运营及确保资金安全的情况下,同意公司使用不超过 1.5 亿元(含 1.5 亿元)闲置募集资金进行现金管理。自公司董事会审议通过之日起 12 个月内有效,在决议有效期内,公司可根据产品期限在可用资金额度内滚动 使用。 具体内容详见公司 2024 年 8 月 24 日披露于《中国证券报》《证券时报》 《 证 券 日 报 》 和 公 司 指 定 信 息 披 露 网 站 巨 潮 资 讯 网 (http://www.cninfo.com.cn)的《关于使用部分闲置募集资 ...
达实智能:智慧医院项目中标 金额为9075万元
证券时报网· 2025-03-16 08:32
Group 1 - The company, Dashi Intelligent (002421), announced on March 16 that its wholly-owned subsidiary, Jiangsu Dashi Jiuxin Medical Technology Co., Ltd., has received a "Notice of Winning Bid" to provide purification and shielding protection professional system services for the new construction project of the Shanghai East Regional Medical Center [1] - The bid amount is 90.7533 million yuan, which accounts for 2.37% of the company's audited operating income for the year 2023 [1]